Provectus Biopharmaceuticals Receives Notice of Allowance for Refractory Pediatric Solid Tumor Cancer Monotherapy and Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office
March 23, 2021 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 23, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent application 16/412,872,...
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
February 01, 2021 19:32 ET
|
Novavax, Inc.
GAITHERSBURG, Md., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that...
Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19
November 05, 2020 08:04 ET
|
Arch Biopartners
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient dosing in Turkey has begun in the Phase...
Grapefruit/IGNG Announces Successful Results in Initial Tests for Efficacy of its Patented Time-Release THC Cannabinoid “Patchless Patch™”
January 08, 2020 06:00 ET
|
Imaging3, Inc.
Los Angeles/Desert Hot Springs, CA, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Grapefruit Boulevard Investments, Inc., (“GBI”) a California based cannabis company and a wholly owned subsidiary of Imaging3,...
Pistol Bay Clarifies Exclusivity Agreement
September 06, 2018 13:20 ET
|
Pistol Bay Mining Inc.
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Pistol Bay Mining Inc. (TSX-V - PST; Frankfurt - 0QSA, OTC/Pink Sheet symbol SLTFF) (“Pistol Bay” or the “Company’) would like to take...
Pistol Bay Signs Exclusivity Agreement for Cannabinoid Herbal Blend
September 05, 2018 09:15 ET
|
Pistol Bay Mining Inc.
VANCOUVER, British Columbia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Pistol Bay Mining Inc. (TSX-V - PST; Frankfurt - OQS2, OTC/Pink Sheet symbol SLTFF) (“Pistol Bay” or the “Company’) is pleased to...
Canntab Brings Pharma Standards to Medical Cannabis -- CFN Media
May 31, 2018 08:42 ET
|
CFN Media
SEATTLE, May 31, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication...
Hemispherx Biopharma Reports New Evidence -- Based Potential of Ampligen(R) Against Ebola Virus Disease (EVD)
October 30, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today a new peer reviewed publication entitled, "The Quest for...